Nancy Perrottet

459 total citations
18 papers, 334 citations indexed

About

Nancy Perrottet is a scholar working on Epidemiology, Oncology and Transplantation. According to data from OpenAlex, Nancy Perrottet has authored 18 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 4 papers in Oncology and 4 papers in Transplantation. Recurrent topics in Nancy Perrottet's work include Cytomegalovirus and herpesvirus research (8 papers), Herpesvirus Infections and Treatments (7 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Nancy Perrottet is often cited by papers focused on Cytomegalovirus and herpesvirus research (8 papers), Herpesvirus Infections and Treatments (7 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Nancy Perrottet collaborates with scholars based in Switzerland, Belgium and Canada. Nancy Perrottet's co-authors include Laurent A. Décosterd, Manuel Pascual, Thierry Buclin, Pascal Meylan, Oriol Manuel, Jérôme Biollaz, Frédéric Lamoth, J Biollaz, Olivier Borens and Andrej Trampuž and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Transplantation.

In The Last Decade

Nancy Perrottet

17 papers receiving 327 citations

Peers

Nancy Perrottet

EPIDE

SURGE

PPCH

PRM

Christopher Kovacs United States

Tracy L. Lemonovich United States

Isabel Oriol Spain

Carlos Armiñanzas Spain

Benjamin Clouzeau France

Vivek Bhat India

Jillian L. Descourouez United States

Julia Origüen Spain

Francesc Barbosa Spain

Heinz J. Schaad Switzerland

Christopher Kovacs United States

Nancy Perrottet

221 ×1.1

EPIDE

44 ×1.0

SURGE

17 ×0.4

PPCH

59 ×1.5

44 ×1.6

PRM

Citations per year, relative to Nancy Perrottet Nancy Perrottet (= 1×) peers Christopher Kovacs

Countries citing papers authored by Nancy Perrottet

Since Specialization

Citations

This map shows the geographic impact of Nancy Perrottet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Perrottet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Perrottet more than expected).

Fields of papers citing papers by Nancy Perrottet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Perrottet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Perrottet. The network helps show where Nancy Perrottet may publish in the future.

Co-authorship network of co-authors of Nancy Perrottet

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Perrottet. A scholar is included among the top collaborators of Nancy Perrottet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Perrottet. Nancy Perrottet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Stavropoulou, Elisavet, Giorgia Caruana, Onya Opota, et al.. (2024). Investigations of an increased incidence of non-Aspergillus invasive mould infections in an onco-haematology unit. Swiss Medical Weekly. 154(3). 3730–3730. 2 indexed citations

Fournier, A, et al.. (2023). Assessing the applicability and appropriateness of ChatGPT in answering clinical pharmacy questions. Annales Pharmaceutiques Françaises. 82(3). 507–513. 16 indexed citations

Décaudin, Bertrand, Pierre Voirol, Nancy Perrottet, Anne Spinewine, & Jean‐François Bussières. (2022). Pharmacie clinique au sein de quatre CHU de la francophonie, intégration et encadrement des pharmaciens cliniciens : une étude exploratoire. Annales Pharmaceutiques Françaises. 81(1). 138–151. 1 indexed citations

Perrottet, Nancy, Mario Fernández‐Ruiz, Isabelle Binet, et al.. (2021). Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study. PLoS ONE. 16(4). e0250829–e0250829. 2 indexed citations

Perrottet, Nancy, Vincent Aubert, Salima Sadallah, et al.. (2020). Upfront use of eculizumab to treat early acute antibody‐mediated rejection after kidney allotransplantation and relevance for xenotransplantation. Xenotransplantation. 27(4). e12630–e12630. 6 indexed citations

Perrottet, Nancy, Déla Golshayan, Samuel Rotman, et al.. (2018). Acute Antibody-Mediated Rejection and its Treatment in Kidney Transplantation. Transplantation. 102(Supplement 7). S93–S93. 1 indexed citations

Chan, Mónica, Erlangga Yusuf, Stefano Giulieri, et al.. (2015). A retrospective study of deep sternal wound infections: clinical and microbiological characteristics, treatment, and risk factors for complications. Diagnostic Microbiology and Infectious Disease. 84(3). 261–265. 41 indexed citations

Yusuf, Erlangga, Nancy Perrottet, Christina Orasch, Olivier Borens, & Andrej Trampuž. (2014). Daptomycin-Associated Eosinophilic Pneumonia in Two Patients with Prosthetic Joint Infection. Surgical Infections. 15(6). 834–837. 8 indexed citations

Perrottet, Nancy, et al.. (2012). Stress ulcer prophylaxis in non‐critically ill patients: a prospective evaluation of current practice in a general surgery department. Journal of Evaluation in Clinical Practice. 19(2). 374–378. 27 indexed citations

10.

Manuel, Oriol, Nancy Perrottet, & Manuel Pascual. (2011). Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation. Expert Review of Anti-infective Therapy. 9(11). 955–965. 7 indexed citations

11.

Manuel, Oriol, Manuel Pascual, Nancy Perrottet, et al.. (2010). Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study. Clinical Transplantation. 24(6). 794–800. 14 indexed citations

12.

Perrottet, Nancy, Oriol Manuel, Frédéric Lamoth, et al.. (2010). Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients. BMC Infectious Diseases. 10(1). 2–2. 25 indexed citations

13.

Perrottet, Nancy, Chantal Csajka, Manuel Pascual, et al.. (2009). Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir. Antimicrobial Agents and Chemotherapy. 53(7). 3017–3023. 41 indexed citations

14.

Perrottet, Nancy, Laurent A. Décosterd, Pascal Meylan, et al.. (2009). Valganciclovir in Adult Solid Organ Transplant Recipients. Clinical Pharmacokinetics. 48(6). 399–418. 62 indexed citations

15.

Keiser, Jennifer, et al.. (2009). Pharmacokinetic parameters of artesunate and dihydroartemisinin in rats infected with Fasciola hepatica. Journal of Antimicrobial Chemotherapy. 63(3). 543–549. 22 indexed citations

16.

Perrottet, Nancy, Pascal Meylan, Manuel Pascual, et al.. (2008). Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients. Journal of Antimicrobial Chemotherapy. 61(6). 1332–1335. 16 indexed citations

17.

Perrottet, Nancy, Alexandre Béguin, Pascal Meylan, et al.. (2007). Determination of aciclovir and ganciclovir in human plasma by liquid chromatography–spectrofluorimetric detection and stability studies in blood samples. Journal of Chromatography B. 852(1-2). 420–429. 39 indexed citations

18.

Buclin, Thierry, Nancy Perrottet, & Jérôme Biollaz. (2005). The importance of assessing the dose actually administered in pharmacokinetic trials. Clinical Pharmacology & Therapeutics. 77(4). 235–240. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact